Metropolitan Life Insurance Company (MetLife)’s Agilon Health AGL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-425	Closed	-$287K	–	2253
2021 Q4	$287K	Buy	425 +250	+143%	+$152K	﹤0.01%	1767
2021 Q3	$114K	Buy	175 +42	+32%	+$35.9K	﹤0.01%	2451
2021 Q2	$135K	Buy	+133	New	+$117K	﹤0.01%	2425

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AGL Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Agilon Health (AGL) in Q1 2022, closing a stake of 425 shares — an estimated $287K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AGL in Q2 2021 and held it in 3 quarters. The position peaked at $287K in Q4 2021. 121 funds tracked by Wall St. Rank hold AGL as of Q1 2022.

Metropolitan Life Insurance Company (MetLife) reported no remaining Agilon Health position as of Q1 2022 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 425 Agilon Health shares in Q1 2022, an estimated $287K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Agilon Health in Q2 2021 and held it in 3 quarters.
Metropolitan Life Insurance Company (MetLife)'s Agilon Health position peaked at $287K in Q4 2021.
121 funds tracked by Wall St. Rank held Agilon Health as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.